The Annexin V-FITC/PI assay has validated the cytotoxic potential, along with the IC50 dose of the complex on MDA-MB-468 breast cancer cells by initiating apoptotic pathway probably due to the cellular energetic stress triggered by elevated ROS levels. Here, ANXA5 is linked to breast carcinoma.